 ExpressMax™ Formula 2 |
|||
| 138 | AthenaES | 500 g | EUR 102 |
 ExpressMax™ Formula 3 |
|||
| 139 | AthenaES | 500 g | EUR 102 |
 ExpressMax™ Formula 4 |
|||
| 140 | AthenaES | 500 g | EUR 102 |
 ExpressMax™ Formula 5 |
|||
| 141 | AthenaES | 500 g | EUR 102 |
 ExpressMax™ Formula 6 |
|||
| 142 | AthenaES | 500 g | EUR 102 |
 ExpressMax™ Formula 7 |
|||
| 143 | AthenaES | 500 g | EUR 102 |
 ExpressMax™ Formula 8 |
|||
| 144 | AthenaES | 500 g | EUR 102 |
 Dodecyltrimethylammonium bromide, 99%, for IPC |
|||
| GE1100-10G | Glentham Life Sciences | 10 g | EUR 118 |
) Cetyldimethylethyl ammonium bromide (Ethylhexadecyldimethylammonium bromide) |
|||
| CB0105 | Bio Basic | 100g | EUR 71.75 |
|
|||
 Rocuronium Bromide |
|||
| A1366-100 | ApexBio | 100 mg | EUR 224 |
|
Description: Rocuronium Bromide is an aminosteroid non-depolarizing neuromuscular blocker. |
|||
Rocuronium Bromide |
|||
| A1366-25 | ApexBio | 25 mg | EUR 108 |
|
Description: Rocuronium Bromide is an aminosteroid non-depolarizing neuromuscular blocker. |
|||
Rocuronium Bromide |
|||
| A1366-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 154 |
|
Description: Rocuronium Bromide is an aminosteroid non-depolarizing neuromuscular blocker. |
|||
 Ethidium Bromide |
|||
| 1203-10 | Biovision | EUR 131 | |
 Hexamethonium Bromide |
|||
| B1592-100000 | ApexBio | 100 g | EUR 235 |
|
Description: Hexamethonium Bromide is a selective antagonist of neuronal-type nicotinic AChR in ganglia. |
|||
Hexamethonium Bromide |
|||
| B1592-25000 | ApexBio | 25 g | EUR 116 |
|
Description: Hexamethonium Bromide is a selective antagonist of neuronal-type nicotinic AChR in ganglia. |
|||
 Neostigmine Bromide |
|||
| B1594-100 | ApexBio | 100 mg | EUR 125 |
|
Description: Neostigmine bromide is a reversible inhibitor of acetylcholinesterase.[1]AChE (acetylcholinesterase) is a hydrolase that hydrolyzes the neurotransmitter acetylcholine at the neuromuscular junction and cholinergic synaspe. |
|||
Neostigmine Bromide |
|||
| B1594-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 108 |
|
Description: Neostigmine bromide is a reversible inhibitor of acetylcholinesterase.[1]AChE (acetylcholinesterase) is a hydrolase that hydrolyzes the neurotransmitter acetylcholine at the neuromuscular junction and cholinergic synaspe. |
|||
Neostigmine Bromide |
|||
| B1594-500 | ApexBio | 500 mg | EUR 189 |
|
Description: Neostigmine bromide is a reversible inhibitor of acetylcholinesterase.[1]AChE (acetylcholinesterase) is a hydrolase that hydrolyzes the neurotransmitter acetylcholine at the neuromuscular junction and cholinergic synaspe. |
|||
 Decamethonium Bromide |
|||
| B1601-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 108 |
|
Description: Decamethonium Bromide is a nicotinic AChR partial agonist and neuromuscular blocking agent. |
|||
Decamethonium Bromide |
|||
| B1601-50 | ApexBio | 50 mg | EUR 128 |
|
Description: Decamethonium Bromide is a nicotinic AChR partial agonist and neuromuscular blocking agent. |
|||
Decamethonium Bromide |
|||
| B1601-S | ApexBio | Evaluation Sample | EUR 81 |
|
Description: Decamethonium Bromide is a nicotinic AChR partial agonist and neuromuscular blocking agent. |
|||
 Homatropine Bromide |
|||
| B1603-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 108 |
|
Description: Homatropine Bromide is muscarinic AChR antagonist, inhibits endothelial and smooth muscle muscarinic receptors of WKY-E and SHR-E with IC50 of 162.5 nM and 170.3 nM, respectively. |
|||
Homatropine Bromide |
|||
| B1603-50 | ApexBio | 50 mg | EUR 128 |
|
Description: Homatropine Bromide is muscarinic AChR antagonist, inhibits endothelial and smooth muscle muscarinic receptors of WKY-E and SHR-E with IC50 of 162.5 nM and 170.3 nM, respectively. |
|||
Homatropine Bromide |
|||
| B1603-S | ApexBio | Evaluation Sample | EUR 81 |
|
Description: Homatropine Bromide is muscarinic AChR antagonist, inhibits endothelial and smooth muscle muscarinic receptors of WKY-E and SHR-E with IC50 of 162.5 nM and 170.3 nM, respectively. |
|||
 Otilonium Bromide |
|||
| B1607-10 | ApexBio | 10 mg | EUR 128 |
|
Description: Otilonium bromide is an antimuscarinic. |
|||
Otilonium Bromide |
|||
| B1607-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 119 |
|
Description: Otilonium bromide is an antimuscarinic. |
|||
Otilonium Bromide |
|||
| B1607-S | ApexBio | Evaluation Sample | EUR 81 |
|
Description: Otilonium bromide is an antimuscarinic. |
|||
 Aclidinium Bromide |
|||
| B1609-10 | ApexBio | 10 mg | EUR 189 |
|
Description: Aclidinium Bromide is a long-acting antagonist of muscarinic (LAMAs) [1].Aclidinium Bromide has been reported to inhibit the specific binding of [3H]-NMS to human M receptors in a dose-denpendent fasion. |
|||
Aclidinium Bromide |
|||
| B1609-100 | ApexBio | 100 mg | EUR 838 |
|
Description: Aclidinium Bromide is a long-acting antagonist of muscarinic (LAMAs) [1].Aclidinium Bromide has been reported to inhibit the specific binding of [3H]-NMS to human M receptors in a dose-denpendent fasion. |
|||
Aclidinium Bromide |
|||
| B1609-5 | ApexBio | 5 mg | EUR 142 |
|
Description: Aclidinium Bromide is a long-acting antagonist of muscarinic (LAMAs) [1].Aclidinium Bromide has been reported to inhibit the specific binding of [3H]-NMS to human M receptors in a dose-denpendent fasion. |
|||
Aclidinium Bromide |
|||
| B1609-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 205 |
|
Description: Aclidinium Bromide is a long-acting antagonist of muscarinic (LAMAs) [1].Aclidinium Bromide has been reported to inhibit the specific binding of [3H]-NMS to human M receptors in a dose-denpendent fasion. |
|||
Aclidinium Bromide |
|||
| B1609-50 | ApexBio | 50 mg | EUR 595 |
|
Description: Aclidinium Bromide is a long-acting antagonist of muscarinic (LAMAs) [1].Aclidinium Bromide has been reported to inhibit the specific binding of [3H]-NMS to human M receptors in a dose-denpendent fasion. |
|||
 Pyridostigmine Bromide |
|||
| B1613-10 | ApexBio | 10 mg | EUR 125 |
|
Description: Pyridostigmine is a parasympathomimetic and a reversible cholinesterase inhibitor. |
|||
Pyridostigmine Bromide |
|||
| B1613-100 | ApexBio | 100 mg | EUR 258 |
|
Description: Pyridostigmine is a parasympathomimetic and a reversible cholinesterase inhibitor. |
|||
Pyridostigmine Bromide |
|||
| B1613-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 108 |
|
Description: Pyridostigmine is a parasympathomimetic and a reversible cholinesterase inhibitor. |
|||
Pyridostigmine Bromide |
|||
| B1613-50 | ApexBio | 50 mg | EUR 171 |
|
Description: Pyridostigmine is a parasympathomimetic and a reversible cholinesterase inhibitor. |
|||
 Domiphen Bromide |
|||
| B1733-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 108 |
|
Description: Domiphen bromide is a quaternary ammonium antiseptic with actions as a cationic surfactant. |
|||
Domiphen Bromide |
|||
| B1733-50 | ApexBio | 50 mg | EUR 128 |
|
Description: Domiphen bromide is a quaternary ammonium antiseptic with actions as a cationic surfactant. |
|||
 SKQ1 Bromide |
|||
| B2584-25 | Biovision | EUR 457 | |
SKQ1 Bromide |
|||
| B2584-5 | Biovision | EUR 153 | |
 Thonzonium Bromide |
|||
| B4962-10 | ApexBio | 10 mg | EUR 139 |
|
Description: Thonzonium Bromide is a surface active agent and an inhibitor of V-ATPase proton transport with EC50 value of 69 µM [1] [2]. Vacuolar ATPases (V-ATPases) are proton pumps that maintain pH homeostasis. |
|||
Thonzonium Bromide |
|||
| B4962-50 | ApexBio | 50 mg | EUR 321 |
|
Description: Thonzonium Bromide is a surface active agent and an inhibitor of V-ATPase proton transport with EC50 value of 69 µM [1] [2]. Vacuolar ATPases (V-ATPases) are proton pumps that maintain pH homeostasis. |
|||
 Cyclopropyl Bromide |
|||
| abx188668-25g | Abbexa | 25 g | EUR 286 |
|
|||
 Didodecyldimethylammonium Bromide |
|||
| abx188680-1kg | Abbexa | 1 kg | EUR 370 |
|
|||
 Pinaverium bromide |
|||
| 20-abx184313 | Abbexa |
|
|
|
|||
 Cyclopropylmethyl bromide |
|||
| 20-abx184666 | Abbexa |
|
|
|
|||
 Sodium bromide |
|||
| 20-abx184772 | Abbexa |
|
|
|
|||
 Tetrabutylammonium bromide |
|||
| 20-abx186047 | Abbexa |
|
|
|
|||
 Tetrahydrofurfuryl bromide |
|||
| 20-abx186582 | Abbexa |
|
|
|
|||
 Ethidium bromide |
|||
| abx082073-1g | Abbexa | 1 g | EUR 217 |
|
|||
 Rocuronium bromide |
|||
| E1KS1397 | EnoGene | 10mg | EUR 247 |
 Tiotropium Bromide |
|||
| A3874-100 | ApexBio | 100 mg | EUR 203 |
|
Description: Tiotropium Bromide is a muscarinic acetylcholine receptor (mAChR M) antagonist that blocks the binding of the acetylcholine ligand and subsequent opening of the ligand-gated ion channel. |
|||
Tiotropium Bromide |
|||
| A3874-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 108 |
|
Description: Tiotropium Bromide is a muscarinic acetylcholine receptor (mAChR M) antagonist that blocks the binding of the acetylcholine ligand and subsequent opening of the ligand-gated ion channel. |
|||
 Umeclidinium bromide |
|||
| A3900-10 | ApexBio | 10 mg | EUR 634 |
|
Description: Umeclidinium bromide is a potent and long-acting antagonist of muscarinic cholinergic receptor (mAChR). |
|||
Umeclidinium bromide |
|||
| A3900-100 | ApexBio | 100 mg | EUR 1887 |
|
Description: Umeclidinium bromide is a potent and long-acting antagonist of muscarinic cholinergic receptor (mAChR). |
|||
Umeclidinium bromide |
|||
| A3900-5 | ApexBio | 5 mg | EUR 416 |
|
Description: Umeclidinium bromide is a potent and long-acting antagonist of muscarinic cholinergic receptor (mAChR). |
|||
Umeclidinium bromide |
|||
| A3900-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 495 |
|
Description: Umeclidinium bromide is a potent and long-acting antagonist of muscarinic cholinergic receptor (mAChR). |
|||
Umeclidinium bromide |
|||
| A3900-50 | ApexBio | 50 mg | EUR 1218 |
|
Description: Umeclidinium bromide is a potent and long-acting antagonist of muscarinic cholinergic receptor (mAChR). |
|||
 Ipratropium Bromide |
|||
| A8451-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 113 |
|
Description: Ipratropium bromide is a mAChR M (muscarinic) antagonist, bronchodilator. N-Isopropyl salt of atropine. |
|||
Ipratropium Bromide |
|||
| A8451-50 | ApexBio | 50 mg | EUR 128 |
|
Description: Ipratropium bromide is a mAChR M (muscarinic) antagonist, bronchodilator. N-Isopropyl salt of atropine. |
|||
 Mepenzolate Bromide |
|||
| A8467-1000 | ApexBio | 1 g | EUR 824 |
|
Description: Mepenzolate bromide occurs as a white or light cream-colored powder, which is freely soluble in methanol, slightly soluble in water and chloroform, and practically insoluble in ether. |
|||
Mepenzolate Bromide |
|||
| A8467-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 125 |
|
Description: Mepenzolate bromide occurs as a white or light cream-colored powder, which is freely soluble in methanol, slightly soluble in water and chloroform, and practically insoluble in ether. |
|||
Mepenzolate Bromide |
|||
| A8467-50 | ApexBio | 50 mg | EUR 209 |
|
Description: Mepenzolate bromide occurs as a white or light cream-colored powder, which is freely soluble in methanol, slightly soluble in water and chloroform, and practically insoluble in ether. |
|||
Mepenzolate Bromide |
|||
| A8467-5000 | ApexBio | 5 g | EUR 1978 |
|
Description: Mepenzolate bromide occurs as a white or light cream-colored powder, which is freely soluble in methanol, slightly soluble in water and chloroform, and practically insoluble in ether. |
|||
 Methylnaltrexone Bromide |
|||
| A3596-10 | ApexBio | 10 mg | EUR 212 |
|
Description: Methylnaltrexone Bromide is an antagonist of mu-opioid receptors (MOR) with IC50 value of 75nM. MOR are a class of opioid receptors with high affinity for enkephalins and beta-endorphin but low affinity for dynorphins. |
|||
Methylnaltrexone Bromide |
|||
| A3596-100 | ApexBio | 100 mg | EUR 1063 |
|
Description: Methylnaltrexone Bromide is an antagonist of mu-opioid receptors (MOR) with IC50 value of 75nM. MOR are a class of opioid receptors with high affinity for enkephalins and beta-endorphin but low affinity for dynorphins. |
|||
Methylnaltrexone Bromide |
|||
| A3596-5 | ApexBio | 5 mg | EUR 158 |
|
Description: Methylnaltrexone Bromide is an antagonist of mu-opioid receptors (MOR) with IC50 value of 75nM. MOR are a class of opioid receptors with high affinity for enkephalins and beta-endorphin but low affinity for dynorphins. |
|||
Methylnaltrexone Bromide |
|||
| A3596-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 168 |
|
Description: Methylnaltrexone Bromide is an antagonist of mu-opioid receptors (MOR) with IC50 value of 75nM. MOR are a class of opioid receptors with high affinity for enkephalins and beta-endorphin but low affinity for dynorphins. |
|||
Methylnaltrexone Bromide |
|||
| A3596-50 | ApexBio | 50 mg | EUR 701 |
|
Description: Methylnaltrexone Bromide is an antagonist of mu-opioid receptors (MOR) with IC50 value of 75nM. MOR are a class of opioid receptors with high affinity for enkephalins and beta-endorphin but low affinity for dynorphins. |
|||
 Vecuronium Bromide |
|||
| A5220-100 | ApexBio | 100 mg | EUR 189 |
|
Description: Vecuronium Bromide is a nonpolarizing neuromuscular relaxant. |
|||